CHRISTIANSON MARK (Business Development Director) sold 3.8% of their position (11.02K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $7.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/21/2025ACC: 0001709738-25-000005
Officer· Business Development Director
Since Feb 2026
-11.02K
Net shares
Net seller
$7.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.02K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.01K
Price / share
$0.67
Trade value
$5.33K
% of position
2.7%
5/19/2025
291.49K→283.49K
Common Stock
Direct
Shares
−3.01K
Price / share
$0.66
Trade value
$1.98K
% of position
1.1%
5/20/2025
283.49K→280.47K
Total
Net shares
−11.02K
Net value
-$7.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2025 | S · Sale | −8.01K | $0.67 | $5.33K | 2.7% | 291.49K | 283.49K |
| Common Stock Direct | 5/20/2025 | S · Sale | −3.01K | $0.66 | $1.98K | 1.1% | 283.49K | 280.47K |
| Total | −11.02K | -$7.31K | ||||||
Derivative Transactions0
No derivative transactions reported